Loading...
Market
Will CVS Caremark make changes to its rebate aggregator subsidiary Zinc by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official statements from CVS Caremark or regulatory filings
Story
CVS Caremark Quietly Agrees to Pay $45 Million to Settle Illinois Drug Rebate Allegations Over Four-Year Period
Jul 23, 2024, 11:18 PM
CVS Caremark has quietly agreed to pay $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to consumers over a recent four-year period. The settlement addresses claims that CVS's pharmacy benefit manager (PBM) inappropriately pocketed drug rebates through a subsidiary known as Zinc, a 'rebate aggregator,' according to a document obtained by STAT.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Announces acquisition • 25%
Announces divestiture • 25%
Announces new business strategy • 25%
No major announcement • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Johnson & Johnson • 25%
Eli Lilly • 25%
Both • 25%
Neither • 25%
Yes • 50%
No • 50%
CEO resignation • 25%
Board restructuring • 25%
No change • 25%
Other changes • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%